taxonomy (8)
protein (22)
source (12)
structure (25)
composition (1)
disease (5)
reference (16)
site (41)
peptide (64)
- Homo sapiens (Human)
- Sus scrofa (Pig)
- Bufo bufo (European toad)
- Rana clamitans (Green frog)
- Drosophila melanogaster (Fruit fly)
- Mamestra brassicae
- Spodoptera frugiperda (Fall armyworm)
- Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Taxonomy
- Ceramide synthase 2 / Homo sapiens Q96G23
- Endoplasmin / Homo sapiens P14625
- Integrin beta-1 / Homo sapiens P05556
- Lactotransferrin / Homo sapiens P02788
- Latent transforming growth factor beta binding protein 1 / Homo sapiens Q14766
- Lysosomal alpha-glucosidase / Homo sapiens P10253
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens P11279
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens P13473
- Monocyte differentiation antigen cd14 / Homo sapiens P08571
- Myeloblastin / Homo sapiens P24158
- Polymeric immunoglobulin receptor / Homo sapiens P01833
- RNA polymerase II elongation factor ELL2 / Homo sapiens O00472
- Uncharacterized protein from Urine / Homo sapiens
- Unspecified mucin / Homo sapiens
- Zinc-alpha-2-glycoprotein / Homo sapiens P25311
- Mucin / Sus scrofa
- Uncharacterized protein from Epithelium of Stomach / Sus scrofa
- Mucin / Bufo bufo
- Mucin / Rana clamitans
- Membrane glycoproteins / Mamestra brassicae
- Membrane glycoproteins / Spodoptera frugiperda
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- Embryo (UBERON_0000922)
- Epithelium of Stomach (UBERON_0001276)
- Mammary Gland (UBERON_0001911)
- Milk (UBERON_0001913)
- Mucosa of Stomach (UBERON_0001199)
- Ovary (UBERON_0000992) Sf21 (CVCL_0518)
- Pulmonary Mucosa
- Urine (UBERON_0001088)
- BTI-Tn-5B1-4 (CVCL_C190) Egg Cell
- BTI-Tn-5B1-4 (CVCL_C190)
- IZD-MB-0503 (CVCL_C411) Hemocyte (CL_0000387)
- Egg Cell Jelly Coat
Source
- N-Linked / Complex / Structure 348
- N-Linked / Complex / Fuc(a1-3)GlcNAc(b1-2)Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-3)GlcNAc(b1-2)Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / GlcNAc(b1-2)Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-3)][Fuc(a1-6)]GlcNAc
- N-Linked / Complex / GlcNAc(b1-2)Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-3)][Fuc(a1-6)]GlcNAc
- N-Linked / Complex / GlcNAc(b1-?)Man(a1-?)[Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-3)][Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 9409
- N-Linked / Hybrid / Structure 9907
- N-Linked / No-core / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / No-core / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / No-core / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-4)Man(a1-3)Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / No-core / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-6)Man(a1-6)Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / No-core / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-3)Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / No-core / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-6)Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / No-core / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-4)Man(a1-3)Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- O-Linked / Core 1 / Fuc(a1-2)Gal(b1-3)GlcNAc(b1-3)[Fuc(a1-2)Gal(b1-4)GlcNAc(b1-6)]Gal(b1-3)GalNAc
- O-Linked / Core 1 / Fuc(a1-2)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)[Gal(b1-4)GlcNAc(b1-6)]Gal(b1-3)GalNAc
- O-Linked / Core 1 / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-3)[Fuc(a1-2)Gal(b1-4)GlcNAc(b1-6)]Gal(b1-3)GalNAc
- O-Linked / Core 1 / Fuc(a1-2)Gal(b1-?)GlcNAc(b1-3)[Fuc(a1-2)Gal(b1-?)GlcNAc(b1-6)]Gal(b1-3)GalNAc
- O-Linked / Core 1 / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-3)GalNAc
- O-Linked / Core 1 / Gal(a1-3)GalNAc(a1-3)[Fuc(a1-2)]Gal(b1-3)[Fuc(a1-2)][GlcNAc(b1-6)]Gal(b1-3)GalNAc
- O-Linked / Core 2 / Fuc(a1-2)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-3)[Gal(b1-4)GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-3)Gal(b1-3)[Fuc(a1-2)Gal(b1-4)GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Fuc(a1-2)Gal(b1-?)GlcNAc(b1-3)Gal(b1-3)[Fuc(a1-2)Gal(b1-4)GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Fuc(a1-3)GlcNAc(b1-6)[Gal(b1-3)]Gal(b1-3)[Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-6)]GalNAc
Reported structure
- Hex:3 HexNAc:3 dHex:2 (avg mass : 1406.3135 )
Composition
- Bronchiectasis, due to Kartagener's Syndrome
- Cancer, breast (DOID:1612)
- COVID-19 (DOID:0080600)
- Cystic Fibrosis (DOID:1485)
- Fucosidosis (DOID:14500)
Disease
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: Implications for vaccination and antibody therapeutics (2020 - Dapeng Zhou, Xiaoxu Tian, Ruibing Qi, Chao Peng, Wen Zhang) / Status : Reviewed
- Quantitative Longitudinal Inventory of the N-Glycoproteome of Human Milk from a Single Donor Reveals the Highly Variable Repertoire and Dynamic Site-Specific Changes (2020 - Jing Zhu, Yu-Hsien Lin, Kelly A Dingess, Marko Mank, Bernd Stahl, Albert J R Heck) / Status : Reviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Automated assignments of N- and O-site specific glycosylation with extensive glycan heterogeneity of glycoprotein mixtures (2013 - Strum JS1, Nwosu CC, Hua S, Kronewitter SR, Seipert RR, Bachelor RJ, An HJ, Lebrilla CB) / Status : Reviewed
- Dynamic Developmental Elaboration of N-Linked Glycan Complexity in the Drosophila melanogaster Embryo (2007 - Kazuhiro Aoki, Mindy Perlman, Jae-Min Lim, Rebecca Cantu, Lance Wells, Michael Tiemeyer) / Status : Reviewed
- Species specificity of O-linked carbohydrate chains of the oviducal mucins in amphibians: structural analysis of neutral oligosaccharide alditols released by reductive beta-elimination from the egg-jelly coats of Rana clamitans. (2002 - Delplace F, Maes E, Lemoine J, Strecker G) / Status : Reviewed
- Hybrid and complex glycans are linked to the conserved N-glycosylation site of the third eight-cysteine domain of LTBP-1 in insect cells. (2000 - Rudd P, Downing A, Cadene M, Harvey D, Wormald M, Weir I, Dwek R, Rifkin D, Gleizes P) / Status : Reviewed
- Structural analysis of hexa to dodecaoligosaccharide-alditols released by reductive beta-elimination from oviducal mucins of Bufo bufo. (1997 - Morelle W, Strecker G) / Status : Reviewed
- Structures of the N-linked oligosaccharides of the membrane glycoproteins from three lepidopteran cell lines (Sf-21, IZD-Mb-0503, Bm-N). (1994 - Kubelka V, Altmann F, Kornfeld G, Mrz L) / Status : Reviewed
- Quantitation and structures of oligosaccharide chains in human trachea mucin glycoproteins. (1992 - Sangadala S, Bhat U, Mendicino J) / Status : Reviewed
- Isolation and structural characterization of novel neutral oligosaccharide-alditols from respitatory-mucus glycoproteins of a patient suffering from bronchiectasis. 2. Structure of twelve hepta-to-nonasaccharide, six of which possess the GlcNAc beta(1----3)[Gal beta(1----4)GlcNAc beta(1----6)]Gal be (1991 - van Kuik J, de Waard P, Vliegenthart J, Klein A, Carnoy C, Lamblin G, Roussel P) / Status : Reviewed
- Characterization and 400-MHz 1H-NMR analysis of urinary fucosyl glycoasparagines in fucosidosis. (1991 - Michalski J, Wieruszeski J, Alonso C, Cache P, Montreuil J, Strecker G) / Status : Reviewed
- Structures of the oligosaccharide chains in swine trachea mucin glycoproteins. (1984 - Chandrasekaran EV, Rana SS, Davila M, Mendicino J) / Status : Reviewed
- Structural characterization of neutral oligosaccharides of human H+Leb+ gastric mucin. (1984 - Slomiany B, Zdebska E, Slomiany A) / Status : Reviewed
- Characterization of the primary structure and the microheterogeneity of the carbohydrate chains of porcine blood-group H substance by 500-MHz 1H-NMR spectroscopy. (1982 - van Halbeek H, Dorland L, Vliegenthart J, Kochetkov N, Arbatsky N, Derevitskaya V) / Status : Reviewed
Reference
- Ceramide synthase 2 / Homo sapiens
- Endoplasmin / Homo sapiens
- Integrin beta-1 / Homo sapiens
- Lactotransferrin / Homo sapiens
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
- Lysosomal alpha-glucosidase / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Monocyte differentiation antigen cd14 / Homo sapiens
- Myeloblastin / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- RNA polymerase II elongation factor ELL2 / Homo sapiens
-
Uncharacterized protein from Urine / Homo sapiens
- Undefined site
-
Unspecified mucin / Homo sapiens
- Undefined site
- Zinc-alpha-2-glycoprotein / Homo sapiens
-
Mucin / Sus scrofa
- Undefined site
-
Uncharacterized protein from Epithelium of Stomach / Sus scrofa
- Undefined site
-
Mucin / Bufo bufo
- Undefined site
-
Mucin / Rana clamitans
- Undefined site
-
Membrane glycoproteins / Mamestra brassicae
- Undefined site
-
Membrane glycoproteins / Spodoptera frugiperda
- Undefined site
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- IWIPVNITWADIEDRDGR (18aa)
- FSNVTWF (7aa)
- TDDEVVQREEEAIQIDGINASQIR (24aa)
- FHAIHVSGTNGTK (13aa)
- HAIHVSGTNGTK (12aa)
- HAIHVSGTNGTKR (13aa)
- KYAGRANLTNFPENGTFVVNIAQLSQDDSGRY (32aa)
- IAVQFGPGFSWIANFTK (17aa)
- KDIVEYYNDSNGSHVLQGRF (20aa)
- LIVNNATNVVIK (12aa)
- IVNNATNVVIK (11aa)
- TQSLLIVNNATNVVIK (16aa)
- VYSSANNCTFE (11aa)
- SEFRVYSSANNCTFE (15aa)
- SSANNCTF (8aa)
- SSANNCTFEY (10aa)
- VGAHDPPAQVLQELNVTVVTFFCRPHNICTFVPR (34aa)
- KDNTTVTR (8aa)
- RCMWSSALNSLNLSFAGLEQVPKG (24aa)
- NGTITDAVDCALDPLSE (17aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- TFLLKYNENGTITDAVDCALDPLSETK (27aa)
- KGIYQTSNFRVQPTESIVRFPNITNLCPFGE (31aa)
- VFNATR (6aa)
- FPNITNLCPFGEVFNATR (18aa)
- GEVFNATR (8aa)
- GVFITNETGQPIIGK (15aa)
- LNNSSPNSSGGVK (13aa)
- KENSSEICSNNGECVCGQCVCR (22aa)
- QDVNCTEVPVAIHADQLTPTWR (22aa)
- QDVNCTEVPVAIHADQL (17aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRR (37aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRAR (39aa)
- AGCLIGAEHVNNSYE (15aa)
- HVNNSYE (7aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- TPPIKDFGGFNFSQILPDPSKPSKR (25aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- DFGGFNFSQILPDPSKPSKR (20aa)
- KNFTTAPAICHDGK (14aa)
- VPAQEKNF (8aa)
- VPAQEKNFTTAPAICHDGK (19aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (41aa)
- GVFVSNGTHWFVTQR (15aa)
- EGVFVSNGTHW (11aa)
- NFTTAPAICHDGK (13aa)
- EGVFVSNGTHWFVTQR (16aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- KNHTSPDVDLGDISGINASVVNIQK (25aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- LNEVAKNLNESLIDLQELGK (20aa)
- NLNESLIDLQELGK (14aa)
- VAKNLNE (7aa)
- IDRLNEVAKNLNESLIDLQE (20aa)
- IDRLNEVAKNLNE (13aa)
- NLNESLIDLQELGKYEQYIK (20aa)
- VAKNLNESLIDLQE (14aa)
- EIDRLNEVAKNLNESLIDLQELGK (24aa)
- CDNVLAPNVTKQECCCTSGVGWGDNCEIFPC (31aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex
(avg mass : 1406.3135)
- Milk (UBERON_0001913)
- Lactotransferrin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1406.3135)
- Urine (UBERON_0001088)
- Fucosidosis (DOID:14500)
-
Uncharacterized protein from Urine / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1406.3135)
- Urine (UBERON_0001088)
- Fucosidosis (DOID:14500)
-
Uncharacterized protein from Urine / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1406.3135)
-
Membrane glycoproteins / Mamestra brassicae
- Undefined site
-
Membrane glycoproteins / Spodoptera frugiperda
- Undefined site
-
- N-Linked / Complex
(avg mass : 1406.3135)
-
Membrane glycoproteins / Mamestra brassicae
- Undefined site
-
Membrane glycoproteins / Spodoptera frugiperda
- Undefined site
-
- N-Linked / Complex
(avg mass : 1406.3135)
- BTI-Tn-5B1-4 (CVCL_C190) Egg Cell
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
- CDNVLAPNVTKQECCCTSGVGWGDNCEIFPC (31aa)
-
- N-Linked / Complex
(avg mass : 1406.3135)
- Milk (UBERON_0001913)
- Monocyte differentiation antigen cd14 / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Zinc-alpha-2-glycoprotein / Homo sapiens
- KYAGRANLTNFPENGTFVVNIAQLSQDDSGRY (32aa)
- KDIVEYYNDSNGSHVLQGRF (20aa)
- RCMWSSALNSLNLSFAGLEQVPKG (24aa)
-
- N-Linked / Hybrid
(avg mass : 1406.3135)
Released - Embryo (UBERON_0000922)
-
- N-Linked / No-core
(avg mass : 1406.3135)
- Urine (UBERON_0001088)
- Fucosidosis (DOID:14500)
-
Uncharacterized protein from Urine / Homo sapiens
- Undefined site
-
- N-Linked / No-core
(avg mass : 1406.3135)
- Urine (UBERON_0001088)
- Fucosidosis (DOID:14500)
-
Uncharacterized protein from Urine / Homo sapiens
- Undefined site
-
- N-Linked / No-core
(avg mass : 1406.3135)
- Urine (UBERON_0001088)
- Fucosidosis (DOID:14500)
-
Uncharacterized protein from Urine / Homo sapiens
- Undefined site
-
- N-Linked / No-core
(avg mass : 1406.3135)
- Urine (UBERON_0001088)
- Fucosidosis (DOID:14500)
-
Uncharacterized protein from Urine / Homo sapiens
- Undefined site
-
- N-Linked / No-core
(avg mass : 1406.3135)
- Urine (UBERON_0001088)
- Fucosidosis (DOID:14500)
-
Uncharacterized protein from Urine / Homo sapiens
- Undefined site
-
- N-Linked / No-core
(avg mass : 1406.3135)
- Urine (UBERON_0001088)
- Fucosidosis (DOID:14500)
-
Uncharacterized protein from Urine / Homo sapiens
- Undefined site
-
- N-Linked / No-core
(avg mass : 1406.3135)
- Urine (UBERON_0001088)
- Fucosidosis (DOID:14500)
-
Uncharacterized protein from Urine / Homo sapiens
- Undefined site
-
- O-Linked / Core 1
(avg mass : 1406.3135)
- Pulmonary Mucosa
-
Unspecified mucin / Homo sapiens
- Undefined site
-
- O-Linked / Core 1
(avg mass : 1406.3135)
- Pulmonary Mucosa
-
Unspecified mucin / Homo sapiens
- Undefined site
-
- O-Linked / Core 1
(avg mass : 1406.3135)
- Isolation and structural characterization of novel neutral oligosaccharide-alditols from respitatory-mucus glycoproteins of a patient suffering from bronchiectasis. 2. Structure of twelve hepta-to-nonasaccharide, six of which possess the GlcNAc beta(1----3)[Gal beta(1----4)GlcNAc beta(1----6)]Gal be (1991 - van Kuik J, de Waard P, Vliegenthart J, Klein A, Carnoy C, Lamblin G, Roussel P) / Status : Reviewed
- Characterization of the primary structure and the microheterogeneity of the carbohydrate chains of porcine blood-group H substance by 500-MHz 1H-NMR spectroscopy. (1982 - van Halbeek H, Dorland L, Vliegenthart J, Kochetkov N, Arbatsky N, Derevitskaya V) / Status : Reviewed
-
Unspecified mucin / Homo sapiens
- Undefined site
-
Uncharacterized protein from Epithelium of Stomach / Sus scrofa
- Undefined site
-
- O-Linked / Core 1
(avg mass : 1406.3135)
-
Unspecified mucin / Homo sapiens
- Undefined site
-
- O-Linked / Core 1
(avg mass : 1406.3135)
- Pulmonary Mucosa
-
Unspecified mucin / Homo sapiens
- Undefined site
-
- O-Linked / Core 1
(avg mass : 1406.3135)
- Egg Cell Jelly Coat
-
Mucin / Bufo bufo
- Undefined site
-
- O-Linked / Core 2
(avg mass : 1406.3135)
- Pulmonary Mucosa
-
Unspecified mucin / Homo sapiens
- Undefined site
-
- O-Linked / Core 2
(avg mass : 1406.3135)
- Pulmonary Mucosa
-
Mucin / Sus scrofa
- Undefined site
-
- O-Linked / Core 2
(avg mass : 1406.3135)
- Pulmonary Mucosa
- Cystic Fibrosis (DOID:1485)
-
Unspecified mucin / Homo sapiens
- Undefined site
-
- O-Linked / Core 2
(avg mass : 1406.3135)
- Egg Cell Jelly Coat
-
Mucin / Rana clamitans
- Undefined site
-
- Hex:3 HexNAc:3 dHex:2 / N-Linked
(avg mass : 1406.3135)
- N-Linked / Complex / Structure 348
- N-Linked / Complex / Fuc(a1-3)GlcNAc(b1-2)Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-3)GlcNAc(b1-2)Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / GlcNAc(b1-2)Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-3)][Fuc(a1-6)]GlcNAc
- N-Linked / Complex / GlcNAc(b1-2)Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-3)][Fuc(a1-6)]GlcNAc
- N-Linked / Complex / GlcNAc(b1-?)Man(a1-?)[Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-3)][Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 9409
- N-Linked / Hybrid / Structure 9907
- N-Linked / No-core / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / No-core / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / No-core / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-4)Man(a1-3)Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / No-core / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-6)Man(a1-6)Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / No-core / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-3)Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / No-core / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-6)Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / No-core / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-4)Man(a1-3)Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: Implications for vaccination and antibody therapeutics (2020 - Dapeng Zhou, Xiaoxu Tian, Ruibing Qi, Chao Peng, Wen Zhang) / Status : Reviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Automated assignments of N- and O-site specific glycosylation with extensive glycan heterogeneity of glycoprotein mixtures (2013 - Strum JS1, Nwosu CC, Hua S, Kronewitter SR, Seipert RR, Bachelor RJ, An HJ, Lebrilla CB) / Status : Reviewed
- Ceramide synthase 2 / Homo sapiens
- Endoplasmin / Homo sapiens
- Integrin beta-1 / Homo sapiens
- Lysosomal alpha-glucosidase / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Myeloblastin / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- RNA polymerase II elongation factor ELL2 / Homo sapiens
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- IWIPVNITWADIEDRDGR (18aa)
- FSNVTWF (7aa)
- TDDEVVQREEEAIQIDGINASQIR (24aa)
- FHAIHVSGTNGTK (13aa)
- HAIHVSGTNGTK (12aa)
- HAIHVSGTNGTKR (13aa)
- IAVQFGPGFSWIANFTK (17aa)
- LIVNNATNVVIK (12aa)
- IVNNATNVVIK (11aa)
- TQSLLIVNNATNVVIK (16aa)
- VYSSANNCTFE (11aa)
- SEFRVYSSANNCTFE (15aa)
- SSANNCTF (8aa)
- SSANNCTFEY (10aa)
- VGAHDPPAQVLQELNVTVVTFFCRPHNICTFVPR (34aa)
- KDNTTVTR (8aa)
- NGTITDAVDCALDPLSE (17aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- TFLLKYNENGTITDAVDCALDPLSETK (27aa)
- KGIYQTSNFRVQPTESIVRFPNITNLCPFGE (31aa)
- VFNATR (6aa)
- FPNITNLCPFGEVFNATR (18aa)
- GEVFNATR (8aa)
- GVFITNETGQPIIGK (15aa)
- LNNSSPNSSGGVK (13aa)
- KENSSEICSNNGECVCGQCVCR (22aa)
- QDVNCTEVPVAIHADQLTPTWR (22aa)
- QDVNCTEVPVAIHADQL (17aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRR (37aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRAR (39aa)
- AGCLIGAEHVNNSYE (15aa)
- HVNNSYE (7aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- TPPIKDFGGFNFSQILPDPSKPSKR (25aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- DFGGFNFSQILPDPSKPSKR (20aa)
- KNFTTAPAICHDGK (14aa)
- VPAQEKNF (8aa)
- VPAQEKNFTTAPAICHDGK (19aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (41aa)
- GVFVSNGTHWFVTQR (15aa)
- EGVFVSNGTHW (11aa)
- NFTTAPAICHDGK (13aa)
- EGVFVSNGTHWFVTQR (16aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- KNHTSPDVDLGDISGINASVVNIQK (25aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- LNEVAKNLNESLIDLQELGK (20aa)
- NLNESLIDLQELGK (14aa)
- VAKNLNE (7aa)
- IDRLNEVAKNLNESLIDLQE (20aa)
- IDRLNEVAKNLNE (13aa)
- NLNESLIDLQELGKYEQYIK (20aa)
- VAKNLNESLIDLQE (14aa)
- EIDRLNEVAKNLNESLIDLQELGK (24aa)
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:3 dHex:2 / N-Linked
(avg mass : 1406.3135)
Source
Reported glycosite
- O-Linked / Core 2
(avg mass : 1406.3135)
Source
Disease
Reported glycosite
- O-Linked / Core 2
(avg mass : 1406.3135)
Source
Reported glycosite
- O-Linked / Core 2
(avg mass : 1406.3135)
Source
Reported glycosite
- O-Linked / Core 2
(avg mass : 1406.3135)
Source
Reported glycosite
- O-Linked / Core 1
(avg mass : 1406.3135)
Source
Reported glycosite
- O-Linked / Core 1
(avg mass : 1406.3135)
Reported glycosite
- O-Linked / Core 1
(avg mass : 1406.3135)
Reference
Reported glycosite
- O-Linked / Core 1
(avg mass : 1406.3135)
Source
Reported glycosite
- O-Linked / Core 1
(avg mass : 1406.3135)
Source
Reported glycosite
- O-Linked / Core 1
(avg mass : 1406.3135)
Source
Disease
Reported glycosite
- N-Linked / No-core
(avg mass : 1406.3135)
Source
Disease
Reported glycosite
- N-Linked / No-core
(avg mass : 1406.3135)
Source
Disease
Reported glycosite
- N-Linked / No-core
(avg mass : 1406.3135)
Source
Disease
Reported glycosite
- N-Linked / No-core
(avg mass : 1406.3135)
Source
Disease
Reported glycosite
- N-Linked / No-core
(avg mass : 1406.3135)
Source
Disease
Reported glycosite
- N-Linked / No-core
(avg mass : 1406.3135)
Source
Disease
Reported glycosite
- N-Linked / No-core
(avg mass : 1406.3135)
Source
Reported glycosite
- N-Linked / Hybrid
(avg mass : 1406.3135)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 1406.3135)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 1406.3135)
Reported glycosite
- N-Linked / Complex
(avg mass : 1406.3135)
Reported glycosite
- N-Linked / Complex
(avg mass : 1406.3135)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1406.3135)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1406.3135)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1406.3135)
